Skip to main content

Wine and breast cancer risk with BRCA mutation

One of the more significant developments in the understanding of breast cancer risk factors was the discovery of two inheritable genetic mutations, BRCA1 and BRCA2, that dramatically increase the lifetime risk of breast cancer. These mutations are aberrant forms of a class of genes called “tumor suppressors” so when they don’t function normally, cancers are more likely to develop and spread. (Tests are available for these mutations and many women with BRCA are opting for prophylactic mastectomy and reconstruction.)


Since alcohol consumption is generally regarded as a risk factor for breast cancer, it is important to know how it might affect women with BRCA. Given all of the confusion about whether wine consumption increases or decreases risk, it becomes even more important to know what to recommend. Surely, the knowledge of a high risk of cancer and not being able to have a glass of wine with dinner seems like double punishment. Fortunately a recent study helps to provide some guidance.

The study, from a collaboration called the Hereditary Breast Cancer Clinical Study Group, analyzed matched pairs of breast cancer patients with and without each type of BRCA mutation, according to a range of lifestyle factors. It’s a powerful study because of the numbers of patients surveyed, nearly 2 thousand, and its broad reach from several countries, though most were from Canada and the U.S.

After statistical adjustments for other known factors, there was no increase in risk from moderate alcohol consumption. Some studies have actually found decreased odds of developing cancer among moderate drinkers with BRCA, but in this study the reduction was only seen in wine drinkers. The implication of this is that it is the wine that is responsible for lowering the risk seen in previous analyses where drinking could not be accurately subdivided by type of beverage. This meshes well with findings on breast cancer risk without the BRCA mutation.

Several compounds unique to red wine have impressive anti-cancer properties, specifically for breast cancer. Clinical trials using some of these compounds in conjunction with traditional therapy are underway. But if you or someone close to you has a strong family history of breast cancer, getting tested for the BRCA gene can save their life. The good news is that they can still share a glass of wine with you and not add to their worries.


Dennis J, Ghadirian P, Little J, Lubinski J, Gronwald J, Kim-Sing C, Foulkes W, Moller P, Lynch HT, Neuhausen SL, Domchek S, Armel S, Isaacs C, Tung N, Sweet K, Ainsworth P, Sun P, Krewski D, Narod S; the Hereditary Breast Cancer Clinical Study Group. Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers. The Breast 2010;e-pub.

Comments

Popular posts from this blog

Wear red and DRINK red for women’s heart health

This Friday Feb 2nd is the annual “wear red” day in Canada and the U.S. to raise awareness for women’s heart health. Why only a day for the number one threat to women’s health? Women are 5 times more likely to succumb to heart disease than breast cancer, which gets a whole month (October.) Another contradiction is that the advice women hear about prevention of breast cancer is the opposite of what you can do to lower the risk of heart disease: a daily glass of wine. Even one drink a day raises your risk of breast cancer, we are told, ignoring the overriding benefits of wine on heart health. Drink red wine to live longer Here’s why I think women should also “drink red.” For starters, wine helps de-stress and celebrates life. Stress is a factor in heart disease, and if that were the only way wine helped it would be worth considering. But the medical evidence is also strong: a daily glass of red wine helps raise the HDL “good cholesterol” levels, which lowers the risk of cardiovascular p…

Which types of wine are the healthiest?

I am often asked after lecturing on the healthful properties of wine which type is best to drink. Since much of the discussion has to do with the polyphenol antioxidants from the skins and seeds of the grape, red wine is the first criterion since it is fermented with the whole grape rather than the pressed juice. This allows for extraction and concentration of these compounds, familiar ones being resveratrol and tannins. But beyond that, which varietals have the highest concentrations?


According to the Roman philosopher Pliny the Elder, “The best kind of wine is that which is pleasant to him that drinks it” but modern science expects more specifics. (The point of course is that if you have a wine that you enjoy you are more likely to drink regularly and therefore reap the benefits.) But there are several difficulties in singling out certain wines for their healthful properties. Which compounds to measure? Are we talking about heart health or the whole gamut? Is it the varietal of the …

The J-curve is dead. Long live the J-curve!

There is a resurgence of debate about the validity of the J-curve, especially as it relates to alcohol and cancer. A 2014 report determined that “alcohol use was positively associated with overall mortality, alcohol-related cancers, and violent death and injuries, but marginally to CVD/CHD” (cardiovascular disease). In other words, there was little benefit if any in terms of heart disease but a big upside risk for cancer and accidental or violent demise. Gone was the French Paradox! The J curve is dead! Or not. Though that statement may be technically true, I looked at look at the data myself and found something different: a strong confirmation of the J-curve for overall mortality, overall cancer deaths, cardiovascular disease, and all “other causes.” This held for both men and women:
    Used under creative commons license from Ferrari P, Licaj I,Muller DC, et al. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and nu…